Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001336504-25-000009
Filing Date
2025-12-23
Accepted
2025-12-23 21:42:34
Documents
1
Period of Report
2025-12-19

Document Format Files

Seq Description Document Type Size
1 form4-12242025_021230.html 4  
1 form4-12242025_021230.xml 4 22131
  Complete submission text file 0001336504-25-000009.txt   23504
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address
CLARK IAN T (Reporting) CIK: 0001336504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 251602271

Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)